Patents Assigned to Mico Bio, Inc.
  • Tuberculosis vaccine and method of using same
    Patent number: 9636391
    Abstract: Provided is a pharmaceutical composition that includes one or more inactivated Mycobacterium spp., which are preferably inactivated using gamma irradiation, and which is then formulated for mucosal or pulmonary delivery to a subject. The pharmaceutical compositions are useful for preventing or treating mycobacterium-associated infections in a subject, including a human subject.
    Type: Grant
    Filed: December 5, 2014
    Date of Patent: May 2, 2017
    Assignee: Mico Bio, Inc.
    Inventors: Jason Fisher, Jennifer Lighter
  • Tuberculosis vaccine and method of using same
    Patent number: 8932608
    Abstract: Provided is a pharmaceutical composition that includes one or more inactivated Mycobacterium spp., which are preferably inactivated using gamma irradiation, and which is than formulated for mucosal or pulmonary delivery to a subject. The pharmaceutical compositions are useful for preventing or treating mycobacterium-associated infections in a subject, including a human subject.
    Type: Grant
    Filed: February 11, 2013
    Date of Patent: January 13, 2015
    Assignee: Mico Bio, Inc.
    Inventors: Jason Fisher, Jennifer Lighter
  • Composition and Method for Enhancing an Immune Response
    Publication number: 20140037700
    Abstract: Disclosed are methods and compositions for treating or preventing microbial infections.
    Type: Application
    Filed: April 19, 2012
    Publication date: February 6, 2014
    Applicant: MICO BIO, INC.
    Inventor: Jason Fisher
  • Tuberculosis Vaccine And Method Of Using Same
    Publication number: 20130273110
    Abstract: Provided is a pharmaceutical composition that includes one or more inactivated Mycobacterium spp., which are preferably inactivated using gamma irradiation, and which is than formulated for mucosal or pulmonary delivery to a subject. The pharmaceutical compositions are useful for preventing or treating mycobacterium-associated infections in a subject, including a human subject.
    Type: Application
    Filed: February 11, 2013
    Publication date: October 17, 2013
    Applicant: MICO BIO, INC.
    Inventors: Jason Fisher, Jennifer Lighter
  • Tuberculosis vaccine and method of using same
    Patent number: 8394389
    Abstract: Provided is a pharmaceutical composition that includes one or more inactivated Mycobacterium spp., which are preferably inactivated using gamma irradiation, and which is then formulated for mucosal or pulmonary delivery to a subject. The pharmaceutical compositions are useful for preventing or treating mycobacterium-associated infections in a subject, including a human subject.
    Type: Grant
    Filed: April 11, 2008
    Date of Patent: March 12, 2013
    Assignee: Mico Bio, Inc.
    Inventors: Jennifer Lighter, Jason Fisher